FindTrial
Sign In

Effects of ingesting 5-aminolaevulinic acids (ALA) on cardiovascular, respiratory, and metabolic function during exercise

Effects of ingesting 5-aminolaevulinic acids (ALA) on cardiovascular, respiratory, and metabolic function during exercise - Ingestion of ALA and physiological functions during exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000004684
Enrollment
15
Registered
2010-12-08
Start date
2010-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

100g/day of ALA ingestion for 1 week-&gt
placebo placebo -&gt
100g/day of ALA ingestion for 1 wee

Sponsors

Department of Sports Medical Sciences, Institute of Pathogenesis and Disease Prevention, Shinshu University, Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: healthy and non-smoking males whoes participation is voluntary.

Exclusion criteria

Exclusion criteria: a patient with disease and smoker

Design outcomes

Primary

MeasureTime frame
ALA ingestion will suppress an increase in blood lactate concentration, resulting in attenuating enhanced ventilation during graded exercise.—

Countries

Japan

Contacts

Public ContactYoshi-ichiro Kamijo

Graduate School of Medicine, Shinshu University Department of Sports Medical Sciences, Institute of Pathogenesis and Disease Prevention

yoshikmj@shinshu-u.ac.jp0263-37-2682

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026